This study is a double-blind, randomized, parallel group, single-dose study design. The study will be conducted in male and female patients ≥ 40 years of age with osteoarthritis of the knee and Type 2 diabetes mellitus. Approximately 36 patients will be randomized to one of the two treatment groups (1:1) and treated with a single intra-articular (IA) injection of: